サマリー

筋骨格系障害（MSD）とは、人体の運動または筋骨格系（筋肉、腱、靭帯、神経、椎間板、血管など）に影響を及ぼす怪我や障害のことである。一般的なMSDは以下の通りです。手根管症候群（Carpal Tunnel Syndrome）。腱鞘炎。筋肉／腱
市場の分析と洞察。筋骨格系疾患治療薬の世界市場
COVID-19の大流行により、筋骨格系障害用医薬品の世界市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルに再調整されると予測されています。この健康危機による経済変化を十分に考慮し、2021年に筋骨格系障害用医薬品の世界市場の％を占めたOTCは、2028年までに百万米ドルの価値を持ち、COVID-19後の期間に修正された％のCAGRで成長すると予測されています。一方、病院部門は、この予測期間を通して％CAGRに変更されています。

中国の筋骨格系疾患用薬剤の市場規模は2021年に100万米ドル、米国と欧州の筋骨格系疾患用薬剤はそれぞれ100万米ドル、100万米ドルと評価されています。米国の割合は2021年に％、中国と欧州はそれぞれ％、％であり、中国の割合は2028年に％に達すると予測され、分析期間を通じてCAGRは％である。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパの筋骨格系疾患治療薬の展望としては、ドイツが2028年までに100万米ドルに達すると予測され、予測期間中のCAGRは%となっています。
筋骨格系疾患治療薬の世界的な主要メーカーは、AbbVie、Amgen、Johnson & Johnson、Roche、Pfizer Inc、Eli Lillyなどです。2021年、世界の上位5社は売上高で約 %のシェアを占めています。

世界の筋骨格系疾患治療薬の範囲とセグメント
筋骨格系疾患治療薬市場は、タイプ別と用途別に分類されます。世界の筋骨格系障害治療薬市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
一般用医薬品
Rx医薬品
用途別セグメント
病院
小売店

会社別
アッヴィー
アムジェン
ジョンソン・エンド・ジョンソン
ロシュ
ファイザー
イーライリリー

地域別
北米
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE

ページTOPに戻る

目次

1 Study Coverage
1.1 Drugs for Musculoskeletal Disorders Product Introduction
1.2 Market by Type
1.2.1 Global Drugs for Musculoskeletal Disorders Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Drugs for Musculoskeletal Disorders Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drugs for Musculoskeletal Disorders Sales Estimates and Forecasts 2017-2028
2.2 Global Drugs for Musculoskeletal Disorders Revenue Estimates and Forecasts 2017-2028
2.3 Global Drugs for Musculoskeletal Disorders Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drugs for Musculoskeletal Disorders Sales by Region
2.4.1 Global Drugs for Musculoskeletal Disorders Sales by Region (2017-2022)
2.4.2 Global Sales Drugs for Musculoskeletal Disorders by Region (2023-2028)
2.5 Global Drugs for Musculoskeletal Disorders Revenue by Region
2.5.1 Global Drugs for Musculoskeletal Disorders Revenue by Region (2017-2022)
2.5.2 Global Drugs for Musculoskeletal Disorders Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drugs for Musculoskeletal Disorders Sales by Manufacturers
3.1.1 Global Top Drugs for Musculoskeletal Disorders Manufacturers by Sales (2017-2022)
3.1.2 Global Drugs for Musculoskeletal Disorders Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drugs for Musculoskeletal Disorders in 2021
3.2 Global Drugs for Musculoskeletal Disorders Revenue by Manufacturers
3.2.1 Global Drugs for Musculoskeletal Disorders Revenue by Manufacturers (2017-2022)
3.2.2 Global Drugs for Musculoskeletal Disorders Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drugs for Musculoskeletal Disorders Revenue in 2021
3.3 Global Drugs for Musculoskeletal Disorders Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drugs for Musculoskeletal Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drugs for Musculoskeletal Disorders Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drugs for Musculoskeletal Disorders Sales by Type
4.1.1 Global Drugs for Musculoskeletal Disorders Historical Sales by Type (2017-2022)
4.1.2 Global Drugs for Musculoskeletal Disorders Forecasted Sales by Type (2023-2028)
4.1.3 Global Drugs for Musculoskeletal Disorders Sales Market Share by Type (2017-2028)
4.2 Global Drugs for Musculoskeletal Disorders Revenue by Type
4.2.1 Global Drugs for Musculoskeletal Disorders Historical Revenue by Type (2017-2022)
4.2.2 Global Drugs for Musculoskeletal Disorders Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drugs for Musculoskeletal Disorders Revenue Market Share by Type (2017-2028)
4.3 Global Drugs for Musculoskeletal Disorders Price by Type
4.3.1 Global Drugs for Musculoskeletal Disorders Price by Type (2017-2022)
4.3.2 Global Drugs for Musculoskeletal Disorders Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drugs for Musculoskeletal Disorders Sales by Application
5.1.1 Global Drugs for Musculoskeletal Disorders Historical Sales by Application (2017-2022)
5.1.2 Global Drugs for Musculoskeletal Disorders Forecasted Sales by Application (2023-2028)
5.1.3 Global Drugs for Musculoskeletal Disorders Sales Market Share by Application (2017-2028)
5.2 Global Drugs for Musculoskeletal Disorders Revenue by Application
5.2.1 Global Drugs for Musculoskeletal Disorders Historical Revenue by Application (2017-2022)
5.2.2 Global Drugs for Musculoskeletal Disorders Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drugs for Musculoskeletal Disorders Revenue Market Share by Application (2017-2028)
5.3 Global Drugs for Musculoskeletal Disorders Price by Application
5.3.1 Global Drugs for Musculoskeletal Disorders Price by Application (2017-2022)
5.3.2 Global Drugs for Musculoskeletal Disorders Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drugs for Musculoskeletal Disorders Market Size by Type
6.1.1 North America Drugs for Musculoskeletal Disorders Sales by Type (2017-2028)
6.1.2 North America Drugs for Musculoskeletal Disorders Revenue by Type (2017-2028)
6.2 North America Drugs for Musculoskeletal Disorders Market Size by Application
6.2.1 North America Drugs for Musculoskeletal Disorders Sales by Application (2017-2028)
6.2.2 North America Drugs for Musculoskeletal Disorders Revenue by Application (2017-2028)
6.3 North America Drugs for Musculoskeletal Disorders Market Size by Country
6.3.1 North America Drugs for Musculoskeletal Disorders Sales by Country (2017-2028)
6.3.2 North America Drugs for Musculoskeletal Disorders Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe Drugs for Musculoskeletal Disorders Market Size by Type
7.1.1 Europe Drugs for Musculoskeletal Disorders Sales by Type (2017-2028)
7.1.2 Europe Drugs for Musculoskeletal Disorders Revenue by Type (2017-2028)
7.2 Europe Drugs for Musculoskeletal Disorders Market Size by Application
7.2.1 Europe Drugs for Musculoskeletal Disorders Sales by Application (2017-2028)
7.2.2 Europe Drugs for Musculoskeletal Disorders Revenue by Application (2017-2028)
7.3 Europe Drugs for Musculoskeletal Disorders Market Size by Country
7.3.1 Europe Drugs for Musculoskeletal Disorders Sales by Country (2017-2028)
7.3.2 Europe Drugs for Musculoskeletal Disorders Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drugs for Musculoskeletal Disorders Market Size by Type
8.1.1 Asia Pacific Drugs for Musculoskeletal Disorders Sales by Type (2017-2028)
8.1.2 Asia Pacific Drugs for Musculoskeletal Disorders Revenue by Type (2017-2028)
8.2 Asia Pacific Drugs for Musculoskeletal Disorders Market Size by Application
8.2.1 Asia Pacific Drugs for Musculoskeletal Disorders Sales by Application (2017-2028)
8.2.2 Asia Pacific Drugs for Musculoskeletal Disorders Revenue by Application (2017-2028)
8.3 Asia Pacific Drugs for Musculoskeletal Disorders Market Size by Region
8.3.1 Asia Pacific Drugs for Musculoskeletal Disorders Sales by Region (2017-2028)
8.3.2 Asia Pacific Drugs for Musculoskeletal Disorders Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Drugs for Musculoskeletal Disorders Market Size by Type
9.1.1 Latin America Drugs for Musculoskeletal Disorders Sales by Type (2017-2028)
9.1.2 Latin America Drugs for Musculoskeletal Disorders Revenue by Type (2017-2028)
9.2 Latin America Drugs for Musculoskeletal Disorders Market Size by Application
9.2.1 Latin America Drugs for Musculoskeletal Disorders Sales by Application (2017-2028)
9.2.2 Latin America Drugs for Musculoskeletal Disorders Revenue by Application (2017-2028)
9.3 Latin America Drugs for Musculoskeletal Disorders Market Size by Country
9.3.1 Latin America Drugs for Musculoskeletal Disorders Sales by Country (2017-2028)
9.3.2 Latin America Drugs for Musculoskeletal Disorders Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Drugs for Musculoskeletal Disorders Market Size by Type
10.1.1 Middle East and Africa Drugs for Musculoskeletal Disorders Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drugs for Musculoskeletal Disorders Revenue by Type (2017-2028)
10.2 Middle East and Africa Drugs for Musculoskeletal Disorders Market Size by Application
10.2.1 Middle East and Africa Drugs for Musculoskeletal Disorders Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drugs for Musculoskeletal Disorders Revenue by Application (2017-2028)
10.3 Middle East and Africa Drugs for Musculoskeletal Disorders Market Size by Country
10.3.1 Middle East and Africa Drugs for Musculoskeletal Disorders Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drugs for Musculoskeletal Disorders Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Drugs for Musculoskeletal Disorders Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AbbVie Drugs for Musculoskeletal Disorders Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Recent Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Overview
11.2.3 Amgen Drugs for Musculoskeletal Disorders Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Amgen Drugs for Musculoskeletal Disorders Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Drugs for Musculoskeletal Disorders Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Johnson & Johnson Drugs for Musculoskeletal Disorders Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Overview
11.4.3 Roche Drugs for Musculoskeletal Disorders Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Roche Drugs for Musculoskeletal Disorders Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Roche Recent Developments
11.5 Pfizer Inc
11.5.1 Pfizer Inc Corporation Information
11.5.2 Pfizer Inc Overview
11.5.3 Pfizer Inc Drugs for Musculoskeletal Disorders Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Inc Drugs for Musculoskeletal Disorders Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Inc Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Corporation Information
11.6.2 Eli Lilly Overview
11.6.3 Eli Lilly Drugs for Musculoskeletal Disorders Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Eli Lilly Drugs for Musculoskeletal Disorders Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eli Lilly Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drugs for Musculoskeletal Disorders Industry Chain Analysis
12.2 Drugs for Musculoskeletal Disorders Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drugs for Musculoskeletal Disorders Production Mode & Process
12.4 Drugs for Musculoskeletal Disorders Sales and Marketing
12.4.1 Drugs for Musculoskeletal Disorders Sales Channels
12.4.2 Drugs for Musculoskeletal Disorders Distributors
12.5 Drugs for Musculoskeletal Disorders Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drugs for Musculoskeletal Disorders Industry Trends
13.2 Drugs for Musculoskeletal Disorders Market Drivers
13.3 Drugs for Musculoskeletal Disorders Market Challenges
13.4 Drugs for Musculoskeletal Disorders Market Restraints
14 Key Findings in The Global Drugs for Musculoskeletal Disorders Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer